Unison Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Unison Advisors's PFE Position: Q3 2026 in Review
Unison Advisors increased its Pfizer (PFE) stake by 1.8% in Q3 2026, buying an estimated $46.6K and bringing the position to 100,240 shares worth $2.86M. The position accounts for 0.2% of the portfolio, ranked #62.
Unison Advisors first reported a position in PFE in Q2 2021 and has held it in 22 quarters since. The position peaked at $4.57M in Q4 2021. 2,877 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Unison Advisors held 100,240 shares of Pfizer worth $2.86M as of Q3 2026.
- Unison Advisors bought 1,752 Pfizer shares in Q3 2026, an estimated $46.6K.
- Pfizer made up 0.2% of Unison Advisors's portfolio in Q3 2026, its #62 holding.
- Unison Advisors first reported a position in Pfizer in Q2 2021 and has held it in 22 quarters since.
- Unison Advisors's Pfizer position peaked at $4.57M in Q4 2021.
- 2,877 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Unison Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.